What are Anti-Bribery and Corruption Laws primarily designed to address?

Anti-Bribery and Corruption Laws are primarily designed to prevent financial incentives that could lead to improper performance. These laws aim to eliminate corrupt practices where individuals or organizations might be unduly influenced to act in a way that is not in the best interest of ethical business conduct or public welfare. By addressing potential bribery and corrupt practices, these laws help ensure that decisions are made based on merit, integrity, and transparency, avoiding conflicts of interest that could compromise the quality of services or products.

Regulating drug prices, enhancing competition among healthcare providers, and limiting pharmaceutical advertising may be important issues within the healthcare sector, but they do not fundamentally align with the primary objectives of Anti-Bribery and Corruption Laws, which focus specifically on promoting fair practices and preventing unethical behavior in business transactions.